Chinmay Munje, MD, PhD from the Paul O’Gorman Leukaemia Research Centre, Glasgow, UK is commenting on the publication "COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS", which was presented at EHA 2019 in Amsterdam
Reference: EHA Library. BARRACO F. Jun 14, 2019; 266478
